Menu

• Ask a Health Expert about THROMBOTIC MICROANGIOPATHY
• Post Your Side Effect related to THROMBOTIC MICROANGIOPATHY
• THROMBOTIC MICROANGIOPATHY and FDA Warnings
• THROMBOTIC MICROANGIOPATHY in Patients Wiki
• Report THROMBOTIC MICROANGIOPATHY in Drug Side Effect Survey

THROMBOTIC MICROANGIOPATHY side effect

What is THROMBOTIC MICROANGIOPATHY ?

A Health Expert wants to answer your question. Please provide details below.

Type your question here

 letters left

Bevacizumab Side Effects Report #5672356-3
Consumer or non-health professional from UNITED STATES reported BEVACIZUMAB problem on Mar 11, 2008. Male patient, 74 years of age, was diagnosed with hepatic neoplasm malignant, hypertension and was treated with BEVACIZUMAB. After drug was administered, patient experienced the following problems/side effects: thrombotic microangiopathy, . BEVACIZUMAB dosage: 7.5 MG/KG, Q2W. During the same period patient was treated with AMLODIPINE. Patient recovered.

Bevacizumab Side Effects Report #5672365-4
BEVACIZUMAB problem was reported by a Consumer or non-health professional from UNITED STATES on Mar 11, 2008. Male patient, 62 years of age, was treated with BEVACIZUMAB. After drug was administered, patient experienced the following problems/side effects: thrombotic microangiopathy, . BEVACIZUMAB dosage: 10 MG/KG, Q2W. During the same period patient was treated with CISPLATIN, TAXOTERE, CYTOXAN. Patient recovered.

Avastin Side Effects Report #5672561-6
Physician from CANADA reported AVASTIN problem on Mar 11, 2008. Female patient, 59 years of age, was diagnosed with ovarian cancer metastatic and was treated with AVASTIN. After drug was administered, patient experienced the following problems/side effects: thrombotic microangiopathy, . AVASTIN dosage: 15 MG/KG, Q3W. Patient died.

Avastin Side Effects Report #5676211-4
AVASTIN problem was reported by a Physician from CANADA on Mar 14, 2008. Male patient, 61 years of age, was diagnosed with pancreatic carcinoma and was treated with AVASTIN. After drug was administered, patient experienced the following problems/side effects: thrombotic microangiopathy, . AVASTIN dosage: 10 MG/KG, Q2W. During the same period patient was treated with ERLOTINIB, GEMCITABINE. Patient recovered.


Avastin Side Effects Report #5683422-0
Physician from CANADA reported AVASTIN problem on Mar 13, 2008. Female patient, 59 years of age, was diagnosed with ovarian cancer metastatic and was treated with AVASTIN. After drug was administered, patient experienced the following problems/side effects: thrombotic microangiopathy, . AVASTIN dosage: 15 MG/KG, Q3W. During the same period patient was treated with GEMCITABINE, CARBOPLATIN. Patient died.

Prograf Side Effects Report #5626157-2
PROGRAF problem was reported by a Physician from JAPAN on Jan 23, 2008. Male patient, 48 years of age, was diagnosed with liver transplant and was treated with PROGRAF. After drug was administered, patient experienced the following problems/side effects: thrombotic microangiopathy, . PROGRAF dosage: unknown. Patient recovered.

Bevacizumab Side Effects Report #5633639-6
Consumer or non-health professional from UNITED STATES reported BEVACIZUMAB problem on Feb 13, 2008. Male patient, 69 years of age, was diagnosed with metastatic renal cell carcinoma and was treated with BEVACIZUMAB. After drug was administered, patient experienced the following problems/side effects: thrombotic microangiopathy, . BEVACIZUMAB dosage: 10 MG/KG, Q2W. During the same period patient was treated with SUTENT. Patient recovered.

Bevacizumab Side Effects Report #5633650-5
BEVACIZUMAB problem was reported by a Physician from UNITED STATES on Feb 13, 2008. Female patient, 54 years of age, was diagnosed with metastatic renal cell carcinoma, headache, hypertension and was treated with BEVACIZUMAB. After drug was administered, patient experienced the following problems/side effects: thrombotic microangiopathy, . BEVACIZUMAB dosage: 10 MG/KG, Q2W. During the same period patient was treated with SUNITINIB MALATE, ALPRAZOLAM, ACETAMINOPHEN, OMEPRAZOLE, DOCUSATE, ALUMINUM MAGNESIUM CARBONATE HYDROXIDE, BISMUTH, NORVASC. Patient recovered.

Bevacizumab Side Effects Report #5633656-6
Physician from UNITED STATES reported BEVACIZUMAB problem on Feb 13, 2008. Male patient, 56 years of age, was diagnosed with metastatic renal cell carcinoma, hypothyroidism, hypertension, gastrooesophageal reflux disease and was treated with BEVACIZUMAB. After drug was administered, patient experienced the following problems/side effects: thrombotic microangiopathy, . BEVACIZUMAB dosage: 10 MG/KG, Q2W. During the same period patient was treated with SUNITINIB MALATE, LEVOTHYROXINE, TRIAMTERENE AND HYDROCHLOROTHIAZIDE, FAMOTIDINE, AMLODIPINE, ESOMEPRAZOLE MAGNESIUM. Patient recovered.


Alkeran Side Effects Report #5585595-7
ALKERAN problem was reported by a Physician from JAPAN on Jan 08, 2008. Female patient, 64 years of age, weighting 121.3 lb, was diagnosed with immunosuppression and was treated with ALKERAN. After drug was administered, patient experienced the following problems/side effects: thrombotic microangiopathy, . ALKERAN dosage: 70MGM2 PER DAY. During the same period patient was treated with FLUDARA, TACROLIMUS HYDRATE, METHOTREXATE, POLYMYXIN B SULPHATE, VANCOMYCIN HYDROCHLORIDE. Patient died on 03/19/2005.

Bevacizumab Side Effects Report #5587232-4
Physician from UNITED STATES reported BEVACIZUMAB problem on Jan 04, 2008. Female patient, 54 years of age, was diagnosed with metastatic renal cell carcinoma, headache, hypertension and was treated with BEVACIZUMAB. After drug was administered, patient experienced the following problems/side effects: thrombotic microangiopathy, . BEVACIZUMAB dosage: 10 MG/KG, Q2W. During the same period patient was treated with SUNITINIB MALATE, ALPRAZOLAM, ACETAMINOPHEN, OMEPRAZOLE, DOCUSATE, ALUMINUM MAGNESIUM CARBONATE HYDROXIDE, BISMUTH, NORVASC. Patient recovered.

Bevacizumab Side Effects Report #5588243-5
BEVACIZUMAB problem was reported by a Consumer or non-health professional from UNITED STATES on Jan 08, 2008. Male patient, 69 years of age, was diagnosed with metastatic renal cell carcinoma and was treated with BEVACIZUMAB. After drug was administered, patient experienced the following problems/side effects: thrombotic microangiopathy, . BEVACIZUMAB dosage: 10 MG/KG, Q2W. During the same period patient was treated with SUTENT. Patient recovered.

Cyclophosphamide Side Effects Report #5590365-X
Consumer or non-health professional from reported CYCLOPHOSPHAMIDE problem on Jan 08, 2008. Male patient, 48 years of age, was diagnosed with immunosuppression and was treated with CYCLOPHOSPHAMIDE. After drug was administered, patient experienced the following problems/side effects: thrombotic microangiopathy, . CYCLOPHOSPHAMIDE dosage: unknown. During the same period patient was treated with TACROLIMUS, MIZORIBINE, ANTITHROMBIN III, PROSTAGLANDIN I. Patient recovered.

Bevacizumab Side Effects Report #5591454-6
BEVACIZUMAB problem was reported by a Physician from UNITED STATES on Jan 08, 2008. Female patient, 85 years of age, was diagnosed with renal cell carcinoma, insomnia, hypertension, hypersensitivity and was treated with BEVACIZUMAB. After drug was administered, patient experienced the following problems/side effects: thrombotic microangiopathy, . BEVACIZUMAB dosage: 10 MG/KG, UNK. During the same period patient was treated with SUNITINIB MALATE, SUNITINIB MALATE, LORAZEPAM, ASCORBIC ACID, CALCIUM, BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE, FEXOFENADINE. Patient was hospitalized. Patient recovered.


Bevacizumab Side Effects Report #5593879-1
Physician from UNITED STATES reported BEVACIZUMAB problem on Jan 08, 2008. Female patient, 79 years of age, was diagnosed with metastatic renal cell carcinoma, anxiety and was treated with BEVACIZUMAB. After drug was administered, patient experienced the following problems/side effects: thrombotic microangiopathy, . BEVACIZUMAB dosage: 10 MG/KG, Q2W. During the same period patient was treated with ACETAMINOPHEN, ALPRAZOLAM. Patient recovered.

Bevacizumab Side Effects Report #5593929-2
BEVACIZUMAB problem was reported by a Physician from UNITED STATES on Jan 08, 2008. Male patient, 56 years of age, was diagnosed with metastatic renal cell carcinoma, hypothyroidism, hypertension, gastrooesophageal reflux disease and was treated with BEVACIZUMAB. After drug was administered, patient experienced the following problems/side effects: thrombotic microangiopathy, . BEVACIZUMAB dosage: 10 MG/KG, Q2W. During the same period patient was treated with SUNITINIB MALATE, LEVOTHYROXINE, TRIAMTERENE AND HYDROCHLOROTHIAZIDE, FAMOTIDINE, AMLODIPINE, ESOMEPRAZOLE MAGNESIUM. Patient recovered.

Sutent Side Effects Report #5596521-9
Consumer or non-health professional from UNITED STATES reported SUTENT problem on Jan 08, 2008. Female patient, 79 years of age, was diagnosed with metastatic renal cell carcinoma and was treated with SUTENT. After drug was administered, patient experienced the following problems/side effects: thrombotic microangiopathy, . SUTENT dosage: unknown. During the same period patient was treated with AVASTIN, ACETAMINOPHEN, ALPRAZOLAM. Patient recovered.

Sutent Side Effects Report #5596537-2
SUTENT problem was reported by a Consumer or non-health professional from UNITED STATES on Jan 08, 2008. Female patient, 54 years of age, was diagnosed with metastatic renal cell carcinoma and was treated with SUTENT. After drug was administered, patient experienced the following problems/side effects: thrombotic microangiopathy, . SUTENT dosage: DAILY DOSE:50MG-FREQ:DAILY. During the same period patient was treated with AVASTIN, ALPRAZOLAM, ACETAMINOPHEN, OMEPRAZOLE, DOCUSATE, ALMAGATE, BISMUTH, NORVASC. Patient recovered.

Sutent Side Effects Report #5596605-5
Consumer or non-health professional from UNITED STATES reported SUTENT problem on Jan 08, 2008. Male patient, 56 years of age, was diagnosed with metastatic renal cell carcinoma and was treated with SUTENT. After drug was administered, patient experienced the following problems/side effects: thrombotic microangiopathy, . SUTENT dosage: unknown. During the same period patient was treated with AVASTIN, LEVOTHYROXINE, TRIAMTERENE AND HYDROCHLOROTHIAZIDE, FAMOTIDINE, AMLODIPINE, ESOMEPRAZOLE MAGNESIUM. Patient recovered.


Cyclophosphamide Side Effects Report #5535241-3
CYCLOPHOSPHAMIDE problem was reported by a Health Professional from JAPAN on Dec 03, 2007. Male patient, 48 years of age, was diagnosed with immunosuppression and was treated with CYCLOPHOSPHAMIDE. After drug was administered, patient experienced the following problems/side effects: thrombotic microangiopathy, . CYCLOPHOSPHAMIDE dosage: 1 FORM = 50-100 MG. During the same period patient was treated with TACROLIMUS, AZATHIOPRINE, MIZORIBINE. Patient recovered.

Cyclophosphamide Side Effects Report #5553454-1
Health Professional from JAPAN reported CYCLOPHOSPHAMIDE problem on Dec 03, 2007. Male patient, 48 years of age, was diagnosed with immunosuppression and was treated with CYCLOPHOSPHAMIDE. After drug was administered, patient experienced the following problems/side effects: thrombotic microangiopathy, . CYCLOPHOSPHAMIDE dosage: 1 FORM = 50-100 MG. During the same period patient was treated with TACROLIMUS, AZATHIOPRINE, MIZORIBINE. Patient recovered.

Bevacizumab Side Effects Report #5572237-X
BEVACIZUMAB problem was reported by a Consumer or non-health professional from UNITED STATES on Dec 14, 2007. Female patient was diagnosed with metastatic renal cell carcinoma and was treated with BEVACIZUMAB. After drug was administered, patient experienced the following problems/side effects: thrombotic microangiopathy, . BEVACIZUMAB dosage: 10 MG/KG, Q2W. During the same period patient was treated with SUTENT. Patient recovered.

Bevacizumab Side Effects Report #5572248-4
Physician from UNITED STATES reported BEVACIZUMAB problem on Dec 14, 2007. Female patient, 85 years of age, was diagnosed with insomnia, hypertension, hypersensitivity and was treated with BEVACIZUMAB. After drug was administered, patient experienced the following problems/side effects: thrombotic microangiopathy, . BEVACIZUMAB dosage: 10 MG/KG, UNK. During the same period patient was treated with SUNITINIB MALATE, SUNITINIB MALATE, LORAZEPAM, ASCORBIC ACID, CALCIUM, BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE, FEXOFENADINE. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5572277-0
BEVACIZUMAB problem was reported by a Physician from UNITED STATES on Dec 14, 2007. Female patient, 56 years of age, was diagnosed with metastatic renal cell carcinoma, hypertension and was treated with BEVACIZUMAB. After drug was administered, patient experienced the following problems/side effects: thrombotic microangiopathy, . BEVACIZUMAB dosage: 10 MG/KG, Q2W. During the same period patient was treated with SUTENT, NORVASC, LANSOPRAZOLE. Patient recovered.

Bevacizumab Side Effects Report #5572278-2
Physician from UNITED STATES reported BEVACIZUMAB problem on Dec 14, 2007. Female patient, 54 years of age, was diagnosed with metastatic renal cell carcinoma, headache, hypertension and was treated with BEVACIZUMAB. After drug was administered, patient experienced the following problems/side effects: thrombotic microangiopathy, . BEVACIZUMAB dosage: 10 MG/KG, Q2W. During the same period patient was treated with SUNITINIB MALATE, ALPRAZOLAM, ACETAMINOPHEN, OMEPRAZOLE, DOCUSATE, ALUMINUM MAGNESIUM CARBONATE HYDROXIDE, BISMUTH, NORVASC. Patient recovered.

Bevacizumab Side Effects Report #5572283-6
BEVACIZUMAB problem was reported by a Physician from UNITED STATES on Dec 14, 2007. Male patient, 56 years of age, was diagnosed with metastatic renal cell carcinoma, hypothyroidism, hypertension, gastrooesophageal reflux disease and was treated with BEVACIZUMAB. After drug was administered, patient experienced the following problems/side effects: thrombotic microangiopathy, . BEVACIZUMAB dosage: 10 MG/KG, Q2W. During the same period patient was treated with SUNITINIB MALATE, LEVOTHYROXINE, TRIAMTERENE AND HYDROCHLOROTHIAZIDE, FAMOTIDINE, AMLODIPINE, ESOMEPRAZOLE MAGNESIUM. Patient recovered.

Bevacizumab Side Effects Report #5572286-1
Physician from UNITED STATES reported BEVACIZUMAB problem on Dec 14, 2007. Female patient, 79 years of age, was diagnosed with metastatic renal cell carcinoma, anxiety and was treated with BEVACIZUMAB. After drug was administered, patient experienced the following problems/side effects: thrombotic microangiopathy, . BEVACIZUMAB dosage: 10 MG/KG, Q2W. During the same period patient was treated with ACETAMINOPHEN, ALPRAZOLAM. Patient recovered.

Pegasys Side Effects Report #5573078-X
PEGASYS problem was reported by a Physician from FRANCE on Dec 11, 2007. Male patient, 56 years of age, was treated with PEGASYS. After drug was administered, patient experienced the following problems/side effects: thrombotic microangiopathy, . PEGASYS dosage: unknown. During the same period patient was treated with REBETOL, CALTRATE, CELECTOL, TAREG, KARDEGIC. Patient was hospitalized. Patient recovered.

Pegasys Side Effects Report #5519986-7
Health Professional from FRANCE reported PEGASYS problem on Nov 06, 2007. Male patient, 56 years of age, was treated with PEGASYS. After drug was administered, patient experienced the following problems/side effects: thrombotic microangiopathy, . PEGASYS dosage: unknown. During the same period patient was treated with REBETOL, CALTRATE, CELECTOL, VALSARTAN, KARDEGIC. Patient was hospitalized. Patient recovered.

Fludara Side Effects Report #5495030-5
FLUDARA problem was reported by a Physician from JAPAN on Oct 10, 2007. Female patient, 46 years of age, was diagnosed with lupus nephritis, prophylaxis and was treated with FLUDARA. After drug was administered, patient experienced the following problems/side effects: thrombotic microangiopathy, . FLUDARA dosage: unknown. During the same period patient was treated with CYCLOSPORINE, CAMPATH, CYCLOPHOSPHAMIDE. Patient recovered.

Prograf Side Effects Report #5504525-7
Physician from JAPAN reported PROGRAF problem on Oct 16, 2007. Female patient, 17 years of age, was treated with PROGRAF. After drug was administered, patient experienced the following problems/side effects: thrombotic microangiopathy, . PROGRAF dosage: unknown. Patient recovered.

Capecitabine Side Effects Report #5442025-3
CAPECITABINE problem was reported by a Physician from AUSTRALIA on Aug 23, 2007. Female patient, 41 years of age, weighting 136.7 lb, was treated with CAPECITABINE. After drug was administered, patient experienced the following problems/side effects: thrombotic microangiopathy, . CAPECITABINE dosage: unknown. During the same period patient was treated with BEVACIZUMAB, MITOMYCIN, PANTOPRAZOLE, METOCLOPRAMIDE. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5467178-2
Consumer or non-health professional from UNITED STATES reported BEVACIZUMAB problem on Sept 13, 2007. Male patient, 59 years of age, was diagnosed with hepatic neoplasm malignant and was treated with BEVACIZUMAB. After drug was administered, patient experienced the following problems/side effects: thrombotic microangiopathy, . BEVACIZUMAB dosage: 7.5 MG/KG, Q2W. Patient recovered.

Bevacizumab Side Effects Report #5467209-X
BEVACIZUMAB problem was reported by a Consumer or non-health professional from UNITED STATES on Sept 13, 2007. Male patient, 56 years of age, was diagnosed with lung neoplasm malignant and was treated with BEVACIZUMAB. After drug was administered, patient experienced the following problems/side effects: thrombotic microangiopathy, . BEVACIZUMAB dosage: 15 MG/KG, Q3W. During the same period patient was treated with ALIMTA. Patient recovered.

Bevacizumab Side Effects Report #5467215-5
Consumer or non-health professional from UNITED STATES reported BEVACIZUMAB problem on Sept 13, 2007. Male patient, 62 years of age, was treated with BEVACIZUMAB. After drug was administered, patient experienced the following problems/side effects: thrombotic microangiopathy, . BEVACIZUMAB dosage: 10 MG/KG, Q2W. During the same period patient was treated with CISPLATIN, TAXOTERE, CYTOXAN. Patient recovered.

Gemzar Side Effects Report #5411944-6
GEMZAR problem was reported by a Physician from UNITED STATES on Aug 03, 2007. Female patient, 33 years of age, was diagnosed with hodgkin's disease and was treated with GEMZAR. After drug was administered, patient experienced the following problems/side effects: thrombotic microangiopathy, . GEMZAR dosage: unknown. During the same period patient was treated with VINORELBINE, DOXORUBICIN. Patient was hospitalized. Patient recovered.

Leflunomide Side Effects Report #5765145-2
Consumer or non-health professional from UNITED STATES reported LEFLUNOMIDE problem on June 02, 2008. Female patient, 51 years of age, was diagnosed with polyomavirus-associated nephropathy and was treated with LEFLUNOMIDE. After drug was administered, patient experienced the following problems/side effects: thrombotic microangiopathy, . LEFLUNOMIDE dosage: unknown. During the same period patient was treated with TACROLIMUS. Patient recovered.

Prograf Side Effects Report #5766324-0
PROGRAF problem was reported by a Physician from JAPAN on May 30, 2008. Male patient, 57 years of age, was diagnosed with bone marrow transplant and was treated with PROGRAF. After drug was administered, patient experienced the following problems/side effects: thrombotic microangiopathy, . PROGRAF dosage: unknown. Patient died.

Thymoglobulin Side Effects Report #5803013-8
Physician from INDIA reported THYMOGLOBULIN problem on June 12, 2008. Female patient was diagnosed with renal transplant and was treated with THYMOGLOBULIN. After drug was administered, patient experienced the following problems/side effects: thrombotic microangiopathy, . THYMOGLOBULIN dosage: unknown. Patient recovered.

Cyclosporine Side Effects Report #5726638-7
CYCLOSPORINE problem was reported by a Consumer or non-health professional from UNITED STATES on Apr 23, 2008. Female patient, 44 years of age, was diagnosed with immunosuppression and was treated with CYCLOSPORINE. After drug was administered, patient experienced the following problems/side effects: thrombotic microangiopathy, . CYCLOSPORINE dosage: unknown. During the same period patient was treated with PREDNISONE, SIROLIMUS. Patient was hospitalized. Patient recovered.

Cyclosporine Side Effects Report #5726640-5
Consumer or non-health professional from UNITED STATES reported CYCLOSPORINE problem on Apr 23, 2008. Male patient, 26 years of age, was diagnosed with immunosuppression and was treated with CYCLOSPORINE. After drug was administered, patient experienced the following problems/side effects: thrombotic microangiopathy, . CYCLOSPORINE dosage: unknown. During the same period patient was treated with TACROLIMUS, SIROLIMUS, PREDNISONE, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL. Patient was hospitalized. Patient recovered.

Mylotarg Side Effects Report #5342340-8
MYLOTARG problem was reported by a Physician from JAPAN on Mar 23, 2007. Female patient, 37 years of age, weighting 97.00 lb, was diagnosed with acute myeloid leukaemia recurrent, prophylaxis and was treated with MYLOTARG. After drug was administered, patient experienced the following problems/side effects: thrombotic microangiopathy, venoocclusive liver disease, . MYLOTARG dosage: unknown. During the same period patient was treated with HEPARIN, FUNGUARD, BUSULFAN, URSO, OMEPRAL. Patient died on 06/21/2006.

Mylotarg Side Effects Report #5283746-5
Physician from JAPAN reported MYLOTARG problem on Mar 23, 2007. Female patient, 37 years of age, weighting 97.00 lb, was diagnosed with acute myeloid leukaemia recurrent, prophylaxis and was treated with MYLOTARG. After drug was administered, patient experienced the following problems/side effects: thrombotic microangiopathy, venoocclusive liver disease, . MYLOTARG dosage: unknown. During the same period patient was treated with HEPARIN, FUNGUARD, BUSULFAN, OMEPRAL. Patient died on 06/21/2006.

Cellcept Side Effects Report #5258647-9
CELLCEPT problem was reported by a Physician from BELGIUM on Feb 28, 2007. Female patient, 17 years of age, was diagnosed with glomerulonephritis membranous and was treated with CELLCEPT. After drug was administered, patient experienced the following problems/side effects: thrombotic microangiopathy, . CELLCEPT dosage: INCREASED TO 750 MG DAILY.. Patient was hospitalized. Patient recovered.

Prograf Side Effects Report #5261579-3
Physician from JAPAN reported PROGRAF problem on Feb 22, 2007. Female patient was diagnosed with stem cell transplant and was treated with PROGRAF. After drug was administered, patient experienced the following problems/side effects: thrombotic microangiopathy, . PROGRAF dosage: 0.02 MG/KG, CONTINUOUS, IV DRIP. During the same period patient was treated with METHOTREXATE. Patient died.

Prograf Side Effects Report #5261581-1
PROGRAF problem was reported by a Physician from JAPAN on Feb 22, 2007. Female patient was diagnosed with stem cell transplant and was treated with PROGRAF. After drug was administered, patient experienced the following problems/side effects: thrombotic microangiopathy, . PROGRAF dosage: 0.02 MG/KG, CONTINUOUS, IV DRIP. During the same period patient was treated with METHOTREXATE. Patient died.

Prograf Side Effects Report #5261583-5
Physician from JAPAN reported PROGRAF problem on Feb 22, 2007. Male patient was treated with PROGRAF. After drug was administered, patient experienced the following problems/side effects: thrombotic microangiopathy, venoocclusive liver disease, . PROGRAF dosage: 0.02 MG, /D, IV DRIP. During the same period patient was treated with MEROPEN, FLUCONAZOLE, FUNGIZONEECTION, CARBENIN. Patient died on 03/25/2003.

Prograf Side Effects Report #5266621-1
PROGRAF problem was reported by a Physician from JAPAN on Feb 26, 2007. Female patient, 34 years of age, was diagnosed with bone marrow transplant and was treated with PROGRAF. After drug was administered, patient experienced the following problems/side effects: thrombotic microangiopathy, . PROGRAF dosage: unknown. Patient died.

Cellcept Side Effects Report #5272727-3
Physician from BELGIUM reported CELLCEPT problem on Mar 13, 2007. Female patient, 17 years of age, was diagnosed with glomerulonephritis membranous and was treated with CELLCEPT. After drug was administered, patient experienced the following problems/side effects: thrombotic microangiopathy, . CELLCEPT dosage: INCREASED TO 750 MG DAILY.. During the same period patient was treated with CORTICOSTEROID NOS. Patient was hospitalized. Patient recovered.

Alkeran Side Effects Report #5664504-6
ALKERAN problem was reported by a Physician from JAPAN on Mar 10, 2008. Male patient, 40 years of age, was treated with ALKERAN. After drug was administered, patient experienced the following problems/side effects: hyperaesthesia, thrombotic microangiopathy, . ALKERAN dosage: 140MGM2 PER DAY. During the same period patient was treated with RANIMUSTINE, ETOPOSIDE, RITUXIMAB. Patient recovered.

Sprycel Side Effects Report #5618778-8
Consumer or non-health professional from FRANCE reported SPRYCEL problem on Feb 01, 2008. Male patient, 73 years of age, was diagnosed with acute lymphocytic leukaemia and was treated with SPRYCEL. After drug was administered, patient experienced the following problems/side effects: confusional state, thrombotic microangiopathy, . SPRYCEL dosage: 03JAN08-10JAN08 140MG,11JAN08-16JAN08 280MG. During the same period patient was treated with VINCRISTINE, METHOTREXATE, DEXAMETHASONE. Patient was hospitalized. Patient recovered.